Systematic use of automated fluorescence-based sequence analysis of amplified genomic DNA for rapid detection of point mutations.
Several approaches are now available for screening populations for known mutations in a given gene. However, for detection of multiple mutations in a population that has not been characterized or for detection of new mutations, the value and efficiency of these screening procedures decreases. Although more than 100 different beta-thalassemia mutations have so far been described, the spectrum of mutations in the Eastern Mediterranean and Israel has not been defined in detail. We have used automated fluorescence-based DNA sequence analysis of PCR-amplified genomic DNA employing a cycle-sequencing strategy coupled with advanced analysis software to rapidly detect beta-thalassemia mutations in Israeli patients. This method enabled rapid identification of eight different mutations in 10 patients, including two rare mutations, one of which has never been described in this geographic region. Our results show that automated fluorescence-based DNA sequence analysis of amplified genomic DNA is a rapid and reliable method for detection of point mutations and small deletions or insertions in both heterozygous and homozygous states. This approach is particularly effective for a relatively small gene such as beta-globin, but it can also be used for rapid detection of mutations in large genes by first sequencing clusters of exons and intron/exon borders.
Tamary
H
H
Division of Hematology, Children's Hospital of Philadelphia, PA 19104.
Surrey
S
S
Kirschmann
H
H
Shalmon
L
L
Zaizov
R
R
Schwartz
E
E
Rappaport
E F
EF
D001331:Automation; D001483:Base Sequence; D017931:DNA Primers / Q000737:chemistry; D016368:Frameshift Mutation; D005796:Genes; D005914:Globins / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D017354:Point Mutation; D017086:beta-Thalassemia / Q000235:genetics*
D017931:DNA Primers; D005914:Globins